09/30/2025
🌟 We’re excited to announce a major advancement in depression care! 🌟
BrainsWay’s accelerated Deep TMS protocol has received FDA clearance and Novus Neurology | Psychiatry | TMS was proud to serve as a site in this pivotal, multi-site clinical trial.
The protocol delivers five treatments per day over six days, followed by eight maintenance sessions across four weeks, offering the same proven efficacy as standard TMS but in a dramatically condensed timeline. In the trial, patients experienced response rates approaching 80%, with many achieving meaningful symptom relief in just over a week.
This breakthrough means individuals struggling with treatment-resistant depression can now access faster, more convenient relief, and we’re honored to have contributed to bringing this innovation forward for our community.
